|
|
||||||||
Eur J Cardiothorac Surg 2000;18:98-103
© 2000 Elsevier Science NL
a Cardio-thoracic Surgery Unit, Poitiers Hospital, Poitiers, France
b Cytokine group, ESA CNRS 6031, IBMIG, Université de Poitiers, 40 Avenue du Recteur Pineau, 86022 Poitiers Cedex, France
c UMR CNRS 6558, Université de Poitiers, Poitiers, France
d DIACLONE Laboratory, Besançon, France
Received 7 October 1999; received in revised form 4 February 2000; accepted 9 February 2000.
Corresponding author. Tel.: +33-5-4945-4057; fax: +33-5-4945-3503
e-mail: jean-claude.lecron{at}campus.univ-poitiers.fr
Objective: Soluble forms of interleukin-6 (IL-6) receptors are known to modulate biological activities of IL-6. The purpose of the study was to measure circulating levels of IL-6, sIL-6R and sgp130 in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass (CPB group) or without CPB (non-CPB group). Methods: The CPB group included 19 patients and the non-CPB group 12 patients. Sera levels of IL-6, sIL-6R and sgp130 were measured by specific ELISA at the beginning of the operation (T0, 15 min before skin incision) and 6 h later (T1). Results: IL-6 sera levels were respectively 9±20 pg/ml (mean±SD) and 13±19 pg/ml at T0 and reached 340±250 pg/ml and 965±1060 pg/ml at T1 in CPB and non-CPB groups, indicating a significant increase from T0 to T1, but no differences between the two groups. When compared to T0 values, sgp130 levels decreased in both groups (respectively 105±37 and 115±35 ng/ml at T0 for CPB and non-CPB groups, and 72±25 and 84±29 ng/ml at T1) while we are not able to detect differences between the groups. Whatever the group or the time, sIL-6R concentrations remained unchanged. Conclusions: We showed that the increase of IL-6 after artery bypass grafting was similar between patients operated with CPB or without CPB. We conclude that the main inductor of IL-6 release is linked to surgical trauma rather than a reaction to CPB. Since it is known that gp130 inhibits IL-6-biological activities, we suggest that the decrease of sgp130 sera levels could further enhance the inflammatory effects of IL-6 in cardiac surgery.
Key Words: Interleukin-6 sIL-6R sgp130 Cardiopulmonary bypass Cardiac surgery
This article has been cited by other articles:
![]() |
G. Brancaccio, E. Villa, E. Girolami, G. Michielon, C. Feltri, E. Mazzera, D. Costa, G. Isacchi, E. Iannace, A. Amodeo, et al. Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process Perfusion, September 1, 2005; 20(5): 263 - 268. [Abstract] [PDF] |
||||
![]() |
J. G. Coles, C. Boscarino, M. Takahashi, D. Grant, A. Chang, J. Ritter, X. Dai, C. Du, G. Musso, H. Yamabi, et al. Cardioprotective stress response in the human fetal heart J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1128 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Biglioli, A. Cannata, F. Alamanni, M. Naliato, M. Porqueddu, M. Zanobini, E. Tremoli, and A. Parolari Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ancey, E. Menet, P. Corbi, S. Fredj, M. Garcia, C. Rucker-Martin, J. Bescond, F. Morel, J. Wijdenes, J.-C. Lecron, et al. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation Cardiovasc Res, July 1, 2003; 59(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputo, M. Yeatman, P. Narayan, G. Marchetto, R. Ascione, B. C. Reeves, and G. D. Angelini Effect of off-pump coronary surgery with right ventricular assist device on organ function and inflammatory response: a randomized controlled trial Ann. Thorac. Surg., December 1, 2002; 74(6): 2088 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Brull, J Sanders, A Rumley, G D Lowe, S E Humphries, and H E Montgomery Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release Heart, March 1, 2002; 87(3): 252 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R Holleyman and D. F Larson Apoptosis in the ischemic reperfused myocardium Perfusion, December 1, 2001; 16(6): 491 - 502. [Abstract] [PDF] |
||||
![]() |
P. Menasche The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2260 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Corbi, M. Rahmati, and J.-C. Lecron Inflammatory response associated with cardiopulmonary bypass and effect of methylprednisolone J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 1052 - 1052. [Full Text] |
||||
![]() |
D.J. Brull, H.E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G.D.O. Lowe, and S.E. Humphries Interleukin-6 Gene -174G>C and -572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1458 - 1463. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |